Aisling Capital Management

Latest statistics and disclosures from Aisling Capital Management's latest quarterly 13F-HR filing:

Companies in the Aisling Capital Management portfolio as of June 2019 quarter

Company (Ticker) Portfolio Weight Share Count Change in Shares Price
Bridgebio Pharma Inc 44.18 3.84M 26.97
Eidos Therapeutics Inc 14.92 1.12M 31.08
Marker Therapeutics Ord 6.77 2.00M 7.92
Obseva Sa 6.70 1.39M 11.31
Avrobio Ord 5.64 811998 16.26
Biohaven Pharmaceutical Holding 5.13 274513 43.79
Aeglea Biotherapeutics 3.78 1.29M 6.85
Atreca Inc Cl A Com 3.12 387653 18.84
Zosano Pharma Corp 2.83 2.03M -87% 3.27
Sunesis Pharmaceuticals Inc Ne 2.37 7.60M 0.73
Nabriva Therapeutics 1.88 1.81M 2.43
Arcus Biosciences Incorporated 1.13 333333 7.95
Verona Pharma Plc ads 0.97 443596 5.10
Aclaris Therapeutics 0.59 634455 2.19

Past 13F-HR SEC Filings by Aisling Capital Management

View All Filings